China Meheco Group Co (SHSE:600056) ROCE %: 7.96% (As of Mar. 2026)


SHSE:600056 China Meheco Group Co Ltd SHSE:600056
63 GF Score
Price ¥8.58
GF Value ¥10.49
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China Meheco Group Co ROCE %?

China Meheco Group Co SHSE:600056 -2.39% 63 ROCE % is 7.96% as of Mar. 2026. GuruFocus rates SHSE:600056 with a GF Score™ of 63/100 and a GF Value™ of ¥10.49 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Meheco Group Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.96%.

China Meheco Group Co  (SHSE:600056) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Meheco Group Co ROCE % Related Terms

China Meheco Group Co ROCE % Historical Data

* Premium members only.

The historical data trend for China Meheco Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Meheco Group Co ROCE % Chart

China Meheco Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.86 7.96 9.89 6.43 6.75

China Meheco Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.57 5.87 7.56 6.09 7.96
SHSE:600056
63GF Score
China Meheco Group Co Ltd SHSE:600056
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Meheco Group Co ROCE % Calculation

China Meheco Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1196.321/( ( (36321.527 - 18002.289) + (36870.97 - 19725.514) )/ 2 )
=1196.321/( (18319.238+17145.456)/ 2 )
=1196.321/17732.347
=6.75 %

China Meheco Group Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1383.784/( ( (36870.97 - 19725.514) + (37477.258 - 19873.929) )/ 2 )
=1383.784/( ( 17145.456 + 17603.329 )/ 2 )
=1383.784/17374.3925
=7.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.96% mean?
China Meheco Group Co (SHSE:600056) has a ROCE % of 7.96% as of Mar. 2026.
Is China Meheco Group Co's ROCE % too high?
China Meheco Group Co's current ROCE % is 7.96%. The Medical Distribution industry median ROCE % is 9.22. China Meheco Group Co's value of 7.96% is 13.7% below this industry median. Overall, China Meheco Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's ROCE % compare to MCK and COR?
China Meheco Group Co's ROCE % of 7.96% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. China Meheco Group Co's value of 7.96% is 13.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Meheco Group Co's current ROCE % of 7.96% is 13.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current ROCE % is 7.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.49, compared to a current price of ¥8.58 — trading 18.2% below its estimated fair value. The current ROCE % is 7.96% and 13.7% below the Medical Distribution industry median of 9.22. China Meheco Group Co's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current ROCE % is 7.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?

Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued. The current stock price of ¥8.58 is trading 18.2% below its estimated GF Value™ of ¥10.49. GuruFocus considers China Meheco Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600056:

  • ROCE %: 7.96%
  • GF Value™: ¥10.49 vs. price of ¥8.58 (18.2% below fair value)
  • GF Score™: 63/100 with 6 warning signs
  • Industry Position: 13.7% below the Medical Distribution median

No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Meheco Group Co Business Description

Address No. 1 Xiying Street, Floor 18-28, Block B, Building 1, General Times Center, District 1, Fengtai, Beijing, CHN, 100073
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
63GF Score

Get the complete analysis for SHSE:600056

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.58
Price
¥10.49
GF Value